Classifying clinical trial portals

Monday, June 15, 2015

A popular driver of clinical trial portal adoption is the desire to improve investigative site staff satisfaction by providing integrated solutions that require fewer credentials, less double data entry and fewer manual paper processes. Other objectives include decreasing study timelines (especially site selection and activation), cutting study costs, improving study team oversight and moving to a paperless environment.

[Read More]

PPD acquires Acurian

Tuesday, August 27, 2013

Wilmington, N.C.-based CRO Pharmaceutical Product Development (PPD) has acquired Acurian, a provider of clinical trial patient enrollment and retention solutions for the life sciences industry. 

[Read More]

i3, Acurian in Patient Recruitment Deal

Tuesday, December 1, 2009

Pharmaceutical services company i3 has entered into an agreement with Acurian, a provider of patient recruitment and retention solutions, to provide study sponsors with a more robust solution to recruit investigators for clinical trials. 

[Read More]

Acurian Offers Performance-based Advertising Contracts

Wednesday, September 10, 2008

Horsham, Pa.-based Acurian has expanded its patient recruitment services to include advertising-based strategies that reduce risks for their clients. Typically, according to Acurian, pharmaceutical, biotech and medical device companies that rely on patient recruitment companies to create centralized advertising campaigns to enroll patients into research studies have little or no recourse if the advertising campaign fails. Acurian’s advertising services offer sponsors performance-based contracts, with payment based on campaign success. Acurian is currently running two large centralized advertising campaigns under performance-based contracts.

[Read More]